Cracking the moody brain: Lifting the mood with ketamine
- 6 December 2010
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 16 (12), 1384-1385
- https://doi.org/10.1038/nm1210-1384
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant DepressionBiological Psychiatry, 2010
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive DisorderJournal of Clinical Psychopharmacology, 2008
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid ReceptorsBiological Psychiatry, 2007
- Psychiatric safety of ketamine in psychopharmacology researchPsychopharmacology, 2007
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- Adaptation of N-Methyl-D-Aspartate (NMDA) Receptors following Antidepressant Treatment: Implications for the Pharmacotherapy of DepressionPharmacopsychiatry, 1996
- Functional antagonists at the NMDA receptor complex exhibit antidepressant actionsEuropean Journal of Pharmacology, 1990
- Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related DrugsScience, 1989